Keyphrases
COVID-19
77%
Alpha Variant
54%
Chikungunya Virus Infection
33%
Epitope
33%
Chronic Impact
33%
Kassala
33%
Novel Antivirals
33%
Chikungunya Virus (CHIKV)
33%
Genetic Origin
33%
SARS-CoV-2-specific T Cells
33%
Phenotypic Screening
33%
Prospective Observational Study
33%
SARS-CoV-2 Delta
33%
Sudan
33%
Hospital Admission
33%
Delta Variant
33%
Epidemiology
33%
Viral mutation
33%
Antiviral Drug Candidate
33%
Clinical Characteristics
33%
Emergency Care
33%
Variants of Concern
33%
Screening Platform
33%
Hospital Emergency
33%
Transmissibility
28%
CD8+
20%
National Lockdown
16%
Caco-2
16%
T Cells
13%
ORF3a
13%
Adjusted Hazard Ratio
11%
Illness
11%
Unvaccinated
11%
PHGDH
11%
False Positive Hits
11%
Caspase 3/7 Activity
11%
Genomic Surveillance
8%
Virus
8%
E484K mutation
8%
Early Summer
8%
Local Authorities
8%
Epidemiological Characterization
8%
Severe Disease
7%
Patients with COVID-19
7%
Healthcare Data
7%
Individual-level Data
7%
Vaccination Status
7%
CD8+ T Cells
6%
T Cell Epitope
6%
Humoral Immunity
6%
Sequence Data
6%
Amino Acid Variation
6%
Killing Assay
6%
T Cell Immunity
6%
T-cell Receptor Repertoire
6%
Cytotoxic Killing
6%
Epitope-specific T Cells
6%
CSF1R
5%
Drug Candidates
5%
Inhibitor-2
5%
Coronavirus
5%
Anti-SARS-CoV-2
5%
Hexokinase
5%
Kinase Inhibitor
5%
Remdesivir
5%
Activity Detection
5%
High-throughput Screening Platform
5%
Cytopathogenic Effect
5%
Cell Culture Model
5%
2-Deoxy-d-glucose (2-DG)
5%
Clinical Development
5%
Superior Performance
5%
Resistant Strains
5%
Drug-induced Phospholipidosis
5%
Medicine and Dentistry
Severe Acute Respiratory Syndrome Coronavirus 2
100%
COVID-19
35%
Antivirus Agent
33%
Emergency Care
33%
Phenotypic Screening
33%
Chikungunya
33%
Cohort Analysis
33%
Cohort Study
33%
Chikungunya Virus
33%
Genetic Epidemiology
33%
Diseases
25%
Caco-2
16%
Hazard Ratio
14%
False Positive Result
11%
Caspase 3
11%
Phosphoglycerate Dehydrogenase
11%
Virus
11%
Health Care
9%
Public Health
8%
Household
8%
Receptor
5%
Cytopathogenic Effect
5%
Remdesivir
5%
Phosphotransferase Inhibitor
5%
Cell Culture
5%
Coronavirus
5%
Phosphotransferase
5%
High Throughput Screening
5%
Colony Stimulating Factor 1
5%
Oxidoreductase Inhibitor
5%
Hexokinase
5%
Sphingolipidoses
5%
Neutron Capture Therapy
5%
Immunology and Microbiology
Severe Acute Respiratory Syndrome Coronavirus 2
66%
Lineages
41%
Viral Disease
33%
Epitope
33%
T Cell
33%
Chikungunya Virus
33%
Virus Nucleocapsid
14%
CD8
14%
Cladistics
10%
Genomic Surveillance
8%
COVID-19
8%
Dynamics
8%
Spike
8%
Virus
8%